- Home
- PMAX vs VERO Comparison
PMAX vs VERO Comparison
Compare PMAX & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PMAX | VERO |
|---|---|---|
| Founded | 2019 | N/A |
| Country | Hong Kong | Canada |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5M | 4.0M |
| IPO Year | 2024 | N/A |
Fundamental Metrics
Financial Performance| Metric | PMAX | VERO |
|---|---|---|
| Price | $2.31 | $8.19 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.0M | ★ 16.4M |
| Earning Date | 09-23-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $4,799,100.00 | ★ $58,876,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $10.00 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.56 | $1.39 |
| 52 Week High | $16.64 | $14.50 |
Technical Indicators
Market Signals| Indicator | PMAX | VERO |
|---|---|---|
| Relative Strength Index (RSI) | 54.77 | 93.12 |
| Support Level | $1.65 | $1.39 |
| Resistance Level | $2.67 | $1.60 |
| Average True Range (ATR) | 0.28 | 0.60 |
| MACD | 0.05 | 0.42 |
| Stochastic Oscillator | 62.61 | 58.85 |
Price Performance
Historical ComparisonAbout PMAX Powell Max Limited
Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. All operations are carried in Hong Kong.
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.